Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SCVM registration revoked:
https://www.sec.gov/litigation/admin/2019/34-86645.pdf
08/14/2019 09:00:1112(j)Registration Revoked by SEC
08/14/2019 09:00:00
SCVM
Scivanta Medical Corp Common Stock
That’s Shitty. Happy I didn’t buy
SCVM SEC Suspension for delinquent Financials:
https://www.sec.gov/litigation/suspensions/2019/34-86529.pdf
Order:
https://www.sec.gov/litigation/suspensions/2019/34-86529-o.pdf
Admin. Proceeding:
https://www.sec.gov/litigation/admin/2019/34-86528.pdf
I DELETED ALL MY DD ON TWITTER... IM TIRED OF FEEDING DONKEYS FREEBIES.
SCVM FTW
$SCVM .... AFTER DOING INTENSE DD... I FOUND OUR POSSIBLE MERGER/ACQUISITION CANDIDATE... THE TECHNOLOGY IF SUCCESSFUL... CAN SAVE MILLIONS OF LIVES #DRUMMONDCERTIFIED https://t.co/2ZrVMyx9QS
https://twitter.com/__FREEMONEY/status/1124560492360454144?s=19
LOL SOLD FOR A LOSE... NOT BUYING THE RETIRED PART LOL
Why would they file that 8k without a follow up? Things are brewing here $SCVM
I JUST WET MYSELF -->> https://twitter.com/__FREEMONEY/status/1124065081992601600?s=19
SCVM 20 MILLY OS!!! FLOAT MAYBE 500K
Looks like my shares will be sitting a while. No trades for almost 24 hours. Ugh.
ONE ON TWITTER PLUS 4??? OMG ONLY 5 TRADERS HERE... EPIC RM OP HERE
https://twitter.com/__FREEMONEY/status/1123598744430080005?s=19
This showed up on the scanners today, tomorrow might get crazy. $SCVM moves on air
I have owned this since the scam of medihut. CEO in jail. Scvm took over symbol many years ago. I just looked. I have no scares. Wtf. Did they bankrupt that symbol? Something is brewing here
No action in 2 hours...wait for more filings.
LETS CLOSE THIS ABOVE A DIME!!!
SCVM FTW
FRFEEMONEY 4 ALL!!!
Got 35k...let's see what happens.
lol then ill just set my sell order at $30
dude just buy those 5s
Bidding for some now...
SCVM NEW INTERIM CEO IN PLACE... #MERGER #ACQUISITION PEEP YESTERDAYS 8K https://t.co/sKvZdHmeSe
https://twitter.com/__FREEMONEY/status/1123598744430080005?s=19
SCVM look how thin this is. 400K volume now $0.08 up
REMEMBER WETM???? YES SIR FREEMONEY N FUNNYG
SCVM booooooom 0.079 HOD
FREEMONEY N FUNNYG
SCVM 0.04 X 0.05, should go fast to silver
AMAZING LOOKS LIKE A SLAP PARTY HERE
SCVM
SCVM less than 1M shares traded in the past 5 years; float should be less than 500K
$SCVM: Moving here... now at $0.04
Sudden 60% mover already.
Must be something in the works.
GO $SCVM
SCVM 8K read it; Merger specialist Leonard Lovallo now the President.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On April 26, 2018, the Board of Directors of the registrant accepted the resignation of Thomas Gifford as President and a member of the registrant’s Board of Directors and appointed Leonard Lovallo as President. Leonard Lovallo, 37, is Managing Member of Millennial Investments, LLC, a consulting firm that he controls, through which he has, since 2014, assisted public and private companies in the areas of mergers, acquisitions, debt restructuring, equity investments and corporate governance. Mr. Lovallo graduated from the State University of New York (Buffalo) with a BA in psychology. In connection with his being appointed as President of the registrant Mr. Lovallo is receiving 500,000 shares of the registrant’s common stock, an award of 1,000,000 shares upon the registrant becoming current in its SEC filings and a salary of $2,000 per month.
https://www.sec.gov/Archives/edgar/data/1093285/000114420419022383/tv520210_8k.htm
SCVM one for 10 reverse split:
http://www.otcbb.com/asp/dailylist_detail.asp?d=04/19/2013&mkt_ctg=NON-OTCBB
Look like the volume and price are starting to move. Anybody know whats going on with SCVM?
Indy... I am not a paid member so I can't pm you. I've been following the company from the start. If you don't mind, send me your email address or some other way to send you a research report on SCVM to get your insight and comments.
hey lshot... thanks for reaching out... actually scvm is a relative new stock for me to follow... do you have any insights that you would like to share?
indy
Followers
|
5
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
41
|
Created
|
10/20/08
|
Type
|
Free
|
Moderators |
Scivanta Medical Corporation Provides Update on the Development of the Hickey Cardiac Monitoring System
Company to commence clinical trials of the Hickey Cardiac Monitoring System
SPRING LAKE, N.J., Oct 14, 2008 /PRNewswire-FirstCall via COMTEX/ -- Scivanta Medical Corporation (OTC Bulletin Board: SCVM), the developer of an innovative product for cardiac monitoring known as the Hickey Cardiac Monitoring System (HCMS), has commenced enrollment of patients for the clinical trials of the HCMS. Scivanta's initial clinical trials will be performed at Kaleida Health/Millard Fillmore Hospital in Buffalo, New York. Scivanta expects to enroll up to 10 patients in this initial study and, upon completion, plans to test at least an additional 40 patients at Kaleida and three other institutions. The clinical trials of the HCMS could be completed as early as December 2008. Upon the successful completion of the clinical trials, Scivanta will submit to the United States Food and Drug Administration (FDA) a 510(k) premarket notification regarding the HCMS. Depending upon the length of the FDA's review, Scivanta estimates that it could have 510(k) clearance from the FDA as early as the beginning of second quarter 2009, which will allow Scivanta to commence sales of the HCMS in the United States shortly thereafter. Scivanta will initially focus its sales efforts on hospitals, for which reimbursement codes currently exist for the procedure performed by the HCMS.
On October 1, 2008, Rivertek Medical Systems, Inc., a medical device development firm located in St. Paul, Minnesota and consultant to Scivanta in the overall development of the HCMS, assumed the development of the hardware component of the HCMS. In connection therewith, Scivanta terminated its development agreement with Sparton Medical Systems, a business group of Sparton Electronics Florida, Inc. Scivanta is currently in discussions with corporate partners regarding the sales and distribution of the HCMS in the United States as well as the manufacturing of the hardware component of the HCMS. Scivanta anticipates that one of its current development partners, Ethox International, Inc., of Buffalo, New York, will manufacture the catheter component of the HCMS.
David LaVance, President and Chief Executive Officer of Scivanta commented, "I am pleased that the HCMS is entering the clinical trial stage of its development. We remain very excited about the prospects of the HCMS and are working diligently to get this product into the United States market. Our product development efforts, which have been done in concert with Ethox International and under the guidance of Rivertek Medical Systems, will continue through the clinical trials, with the expectation that a commercial product will be manufactured and available at the same time as FDA clearance is received."
About Scivanta Medical Corporation
Scivanta Medical Corporation is focused on acquiring and developing medical technologies and products which offer advantages over existing medical procedures and treatments. Scivanta's first product, the Hickey Cardiac Monitoring System, is an innovative cardiac monitoring system that utilizes a two-balloon esophageal catheter to monitor cardiac performance. The HCMS is expected to provide the primary measurements of cardiac performance in a minimally invasive and cost-effective manner and is designed to be used outside of an intensive care setting. The HCMS is currently under development and must receive the appropriate regulatory approvals prior to commercialization. As Scivanta develops the HCMS, it expects to continue to review for acquisition other medical technologies and products that are sold, or capable of being sold, in a specialty or niche market. For more information, visit www.scivanta.com.
Forward-Looking Statements
Statements about the Scivanta's future expectations and all other statements in this press release other than historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, trends and uncertainties that could cause actual results to differ materially from expected results. Among these risks, trends and uncertainties are economic conditions both generally and within the industries in which Scivanta may participate; competition within Scivanta's chosen industries, including competition from much larger competitors; technological advances; available capital; regulatory approval; and failure by Scivanta to successfully develop or acquire products and form new business relationships. Scivanta intends that such forward-looking statements shall be subject to the safe harbors created thereby. Since these statements involve risks and uncertainties and are subject to change at any time, the Scivanta's actual results could differ materially from expected results.
Contacts:
Scivanta Medical Corporation
Tom Gifford, Chief Financial Officer
Tel.: (732) 282-1620 x15
Fax: (732) 282-1621
tgifford@scivanta.com
Catalyst Financial Resources
Investor Relations
Aimee Boutcher
Tel: (973) 239-2878
Fax: (973) 239-2972
aimee@catalystresearch.com
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |